Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-708
Closed -$228K 186
2024
Q3
$228K Sell
708
-100
-12% -$32.7K 0.13% 172
2024
Q2
$252K Buy
+808
New +$237K 0.15% 140
2024
Q1
Sell
-729
Closed -$210K 183
2023
Q4
$210K Sell
729
-32
-4% -$8.72K 0.15% 155
2023
Q3
$205K Sell
761
-294
-28% -$73.4K 0.15% 155
2023
Q2
$234K Buy
1,055
+130
+14% +$30.2K 0.16% 136
2023
Q1
$224K Buy
925
+111
+14% +$27.2K 0.16% 146
2022
Q4
$214K Sell
814
-227
-22% -$60.9K 0.16% 148
2022
Q3
$235K Buy
1,041
+38
+4% +$9.21K 0.19% 119
2022
Q2
$244K Sell
1,003
-2,294
-70% -$562K 0.22% 113
2022
Q1
$797K Sell
3,297
-117
-3% -$26.9K 0.18% 117
2021
Q4
$768K Buy
3,414
+468
+16% +$98.8K 0.21% 103
2021
Q3
$626K Buy
2,946
+1,570
+114% +$361K 0.2% 104
2021
Q2
$335K Buy
1,376
+54
+4% +$13.3K 0.25% 97
2021
Q1
$329K Buy
1,322
+354
+37% +$84.5K 0.27% 93
2020
Q4
$223K Buy
+968
New +$223K 0.2% 117

Other funds holding AMGN

Latitude Advisors's AMGN Position: Q4 2024 in Review

Latitude Advisors sold out of Amgen (AMGN) in Q4 2024, closing a stake of 708 shares — an estimated $228K sold.

Latitude Advisors first reported a position in AMGN in Q4 2020 and held it in 15 quarters. The position peaked at $797K in Q1 2022. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Latitude Advisors reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Latitude Advisors sold 708 Amgen shares in Q4 2024, an estimated $228K.
  • Latitude Advisors first reported a position in Amgen in Q4 2020 and held it in 15 quarters.
  • Latitude Advisors's Amgen position peaked at $797K in Q1 2022.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Latitude Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.